Trial Profile
A Randomized Study Of The Effect Of Exemestane (Aromasin) Versus Placebo On Breast Density In Postmenopausal Women At Increased Risk For Development Of Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 06 Apr 2020
Price :
$35
*
At a glance
- Drugs Exemestane (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- 21 Sep 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 21 Sep 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 18 Mar 2010 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.